A carregar...

Lapatinib: the evidence for its therapeutic value in metastatic breast cancer

INTRODUCTION: Breast cancer is the most common cancer affecting women. Many patients ultimately progress to metastatic disease and optimal management of this disease remains a significant therapeutic challenge. Lapatinib, a dual tyrosine kinase inhibitor, is in clinical development for treatment of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Thomson, Andrew
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2005
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3321658/
https://ncbi.nlm.nih.gov/pubmed/22500146
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!